Actinium-225, an alpha-emitting radiopharmaceutical, targets cancer cells precisely, sparing healthy tissue, and is being trialed for advanced breast cancer in the U.S. The phase 1b/2 trial involves ...
MedPage Today on MSN
Test for Early Pancreatic Cancer Suggests Potential for High-Risk Patients
A panel of four biomarkers had high accuracy for distinguishing cancer from noncancer ...
Pap smears and HPV tests can catch issues early—long before they become cancer. Learn why these simple screenings matter and how to make the experience more comfortable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results